Review



acquisition module mp160  (BIOPAC)

 
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 90
      Buy from Supplier

    Structured Review

    BIOPAC acquisition module mp160
    Acquisition Module Mp160, supplied by BIOPAC, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/acquisition module mp160/product/BIOPAC
    Average 90 stars, based on 1 article reviews
    acquisition module mp160 - by Bioz Stars, 2026-03
    90/100 stars

    Images



    Similar Products

    acquisition module mp160  (BIOPAC)
    90
    BIOPAC acquisition module mp160
    Acquisition Module Mp160, supplied by BIOPAC, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/acquisition module mp160/product/BIOPAC
    Average 90 stars, based on 1 article reviews
    acquisition module mp160 - by Bioz Stars, 2026-03
    90/100 stars
    		  Buy from Supplier
    data acquisition module mp160  (BIOPAC)
    90
    BIOPAC data acquisition module mp160
    Data Acquisition Module Mp160, supplied by BIOPAC, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/data acquisition module mp160/product/BIOPAC
    Average 90 stars, based on 1 article reviews
    data acquisition module mp160 - by Bioz Stars, 2026-03
    90/100 stars
    		  Buy from Supplier
    ecg data acquisition module biopac mp160  (BIOPAC)
    90
    BIOPAC ecg data acquisition module biopac mp160
    Overview of methodologies employed in six distinct studies. The first study (intraperitoneal study) scrutinized a preceding model of takotsubo syndrome and the impact of oxygen supplementation. The ‘infusion time study’ assessed varying durations of infusion (ranging from 1 to 60 min). The ‘dose study’ examined a range of isoprenaline dosages (from 0 to 1 mg/kg). The ‘replication study’ served as a reiteration of the infusion time study. The ‘sex study’ investigated the role of female and male sex in the intravenous model. The ‘strain study’ evaluated the effect of different rat strains and breeders on the newly developed takotsubo syndrome model. High-resolution <t>echocardiography</t> was utilized to assess cardiac function and wall motion abnormalities for a period up to 30 days. Parameters, such as mortality rate, incidence and extent of apical akinesia, and timeframe for recuperation of cardiac function, were investigated across the studies.
    Ecg Data Acquisition Module Biopac Mp160, supplied by BIOPAC, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/ecg data acquisition module biopac mp160/product/BIOPAC
    Average 90 stars, based on 1 article reviews
    ecg data acquisition module biopac mp160 - by Bioz Stars, 2026-03
    90/100 stars
    		  Buy from Supplier
    mp160 data acquisition module  (BIOPAC)
    90
    BIOPAC mp160 data acquisition module
    Overview of methodologies employed in six distinct studies. The first study (intraperitoneal study) scrutinized a preceding model of takotsubo syndrome and the impact of oxygen supplementation. The ‘infusion time study’ assessed varying durations of infusion (ranging from 1 to 60 min). The ‘dose study’ examined a range of isoprenaline dosages (from 0 to 1 mg/kg). The ‘replication study’ served as a reiteration of the infusion time study. The ‘sex study’ investigated the role of female and male sex in the intravenous model. The ‘strain study’ evaluated the effect of different rat strains and breeders on the newly developed takotsubo syndrome model. High-resolution <t>echocardiography</t> was utilized to assess cardiac function and wall motion abnormalities for a period up to 30 days. Parameters, such as mortality rate, incidence and extent of apical akinesia, and timeframe for recuperation of cardiac function, were investigated across the studies.
    Mp160 Data Acquisition Module, supplied by BIOPAC, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/mp160 data acquisition module/product/BIOPAC
    Average 90 stars, based on 1 article reviews
    mp160 data acquisition module - by Bioz Stars, 2026-03
    90/100 stars
    		  Buy from Supplier
    mp160 acquisition module  (BIOPAC)
    90
    BIOPAC mp160 acquisition module
    Overview of methodologies employed in six distinct studies. The first study (intraperitoneal study) scrutinized a preceding model of takotsubo syndrome and the impact of oxygen supplementation. The ‘infusion time study’ assessed varying durations of infusion (ranging from 1 to 60 min). The ‘dose study’ examined a range of isoprenaline dosages (from 0 to 1 mg/kg). The ‘replication study’ served as a reiteration of the infusion time study. The ‘sex study’ investigated the role of female and male sex in the intravenous model. The ‘strain study’ evaluated the effect of different rat strains and breeders on the newly developed takotsubo syndrome model. High-resolution <t>echocardiography</t> was utilized to assess cardiac function and wall motion abnormalities for a period up to 30 days. Parameters, such as mortality rate, incidence and extent of apical akinesia, and timeframe for recuperation of cardiac function, were investigated across the studies.
    Mp160 Acquisition Module, supplied by BIOPAC, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/mp160 acquisition module/product/BIOPAC
    Average 90 stars, based on 1 article reviews
    mp160 acquisition module - by Bioz Stars, 2026-03
    90/100 stars
    		  Buy from Supplier

    Image Search Results


    Overview of methodologies employed in six distinct studies. The first study (intraperitoneal study) scrutinized a preceding model of takotsubo syndrome and the impact of oxygen supplementation. The ‘infusion time study’ assessed varying durations of infusion (ranging from 1 to 60 min). The ‘dose study’ examined a range of isoprenaline dosages (from 0 to 1 mg/kg). The ‘replication study’ served as a reiteration of the infusion time study. The ‘sex study’ investigated the role of female and male sex in the intravenous model. The ‘strain study’ evaluated the effect of different rat strains and breeders on the newly developed takotsubo syndrome model. High-resolution echocardiography was utilized to assess cardiac function and wall motion abnormalities for a period up to 30 days. Parameters, such as mortality rate, incidence and extent of apical akinesia, and timeframe for recuperation of cardiac function, were investigated across the studies.

    Journal: European Heart Journal Open

    Article Title: Development of a small animal model replicating core characteristics of takotsubo syndrome in humans

    doi: 10.1093/ehjopen/oeae048

    Figure Lengend Snippet: Overview of methodologies employed in six distinct studies. The first study (intraperitoneal study) scrutinized a preceding model of takotsubo syndrome and the impact of oxygen supplementation. The ‘infusion time study’ assessed varying durations of infusion (ranging from 1 to 60 min). The ‘dose study’ examined a range of isoprenaline dosages (from 0 to 1 mg/kg). The ‘replication study’ served as a reiteration of the infusion time study. The ‘sex study’ investigated the role of female and male sex in the intravenous model. The ‘strain study’ evaluated the effect of different rat strains and breeders on the newly developed takotsubo syndrome model. High-resolution echocardiography was utilized to assess cardiac function and wall motion abnormalities for a period up to 30 days. Parameters, such as mortality rate, incidence and extent of apical akinesia, and timeframe for recuperation of cardiac function, were investigated across the studies.

    Article Snippet: Data collection and analysis from a lead I electrocardiogram (ECG) were performed using a BIOPAC MP160 ECG data acquisition module (Acknowledge, BIOPAC Systems).

    Techniques:

    Evaluation of 30-day mortality and physiological parameters in the intraperitoneal model with oxygen supplementation. ( A ) Oxygen saturation and body temperature during first 60 min. Mean ± SEM. Two-way repeated-measures analysis of variance; n = 18 per group. * P < 0.05, *** P < 0.001 vs. baseline (no O 2 supplementation group); ¤¤¤ P < 0.001 vs. baseline (O 2 supplementation group). ### P < 0.001 between groups (no O 2 vs. O 2 ). ( B ) Electrocardiogram (ECG) changes from baseline (i) to 60 min (v) after induction. ECG changes (ii) occurred in conjunction with increased heart rate and oxygen saturation drop. These changes were dynamic with (iii) and without (iv) oxygen supplementation. ( C ) Although oxygen supplementation increased survival, high 30-day mortality rates were observed. Results presented assuming Weibull distribution; n = 15 per group; P = 0.026. ( D ) Boxplots depicting the extent of akinesia. Oxygen supplementation did not affect the extent of akinesia. Unpaired two sample t -test; n = 8 and 12 per group. P = 0.91. ( E ) The surviving animals in the oxygen supplemented group had better cardiac function at 2 h. Unpaired two sample t -test; n = 8 and 6 per group. P = 0.022. FAC, fractional area change; SpO 2 , oxygen saturation.

    Journal: European Heart Journal Open

    Article Title: Development of a small animal model replicating core characteristics of takotsubo syndrome in humans

    doi: 10.1093/ehjopen/oeae048

    Figure Lengend Snippet: Evaluation of 30-day mortality and physiological parameters in the intraperitoneal model with oxygen supplementation. ( A ) Oxygen saturation and body temperature during first 60 min. Mean ± SEM. Two-way repeated-measures analysis of variance; n = 18 per group. * P < 0.05, *** P < 0.001 vs. baseline (no O 2 supplementation group); ¤¤¤ P < 0.001 vs. baseline (O 2 supplementation group). ### P < 0.001 between groups (no O 2 vs. O 2 ). ( B ) Electrocardiogram (ECG) changes from baseline (i) to 60 min (v) after induction. ECG changes (ii) occurred in conjunction with increased heart rate and oxygen saturation drop. These changes were dynamic with (iii) and without (iv) oxygen supplementation. ( C ) Although oxygen supplementation increased survival, high 30-day mortality rates were observed. Results presented assuming Weibull distribution; n = 15 per group; P = 0.026. ( D ) Boxplots depicting the extent of akinesia. Oxygen supplementation did not affect the extent of akinesia. Unpaired two sample t -test; n = 8 and 12 per group. P = 0.91. ( E ) The surviving animals in the oxygen supplemented group had better cardiac function at 2 h. Unpaired two sample t -test; n = 8 and 6 per group. P = 0.022. FAC, fractional area change; SpO 2 , oxygen saturation.

    Article Snippet: Data collection and analysis from a lead I electrocardiogram (ECG) were performed using a BIOPAC MP160 ECG data acquisition module (Acknowledge, BIOPAC Systems).

    Techniques: